Biotech company Regeneron Pharmaceuticals lost a bid on Friday to be held immune from allegations that it misused a patented ...
Shares of Regeneron Pharmaceuticals Inc. REGN slumped 0.17% to $1,012.82 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.90% ...
The prevalence of type 2 diabetes, along with related conditions, such as metabolic syndrome and obesity, has increased ...
Regeneron Pharmaceuticals Inc (REGN) stock saw a decline, ending the day at $1014.59 which represents a decrease of $-25.68 or -2.47% from the prior close of $1040.27. The stock opened at $1037.5 and ...
This week, the FDA granted approval to Sanofi SNY and Regeneron’s REGN blockbuster drug, Dupixent, for its sixth indication.
The FDA approved a new strength of a trastuzumab biosimilar; UnitedHealth will remove reference adalimumab from some ...
Blasts Shake Beirut as Israel Targets Hezbollah Leaders, Officials Say Israeli officials said planes bombed a bunker where senior Hezbollah officials were meeting, including the presumed successor ...
The robust hiring in September showed that the labor market remained strong. The unemployment rate dropped to 4.1 percent. Pandemic Start-Ups Are Thriving, and Helping to Fuel the Economy A record ...
The Syfy series will be hitting Netflix in Canada and a handful of other territories in October.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback